W
William T. Creasman
Researcher at Medical University of South Carolina
Publications - 270
Citations - 27942
William T. Creasman is an academic researcher from Medical University of South Carolina. The author has contributed to research in topics: Gynecologic oncology & Endometrial cancer. The author has an hindex of 79, co-authored 269 publications receiving 26714 citations. Previous affiliations of William T. Creasman include University of Texas at Austin & University of Southern California.
Papers
More filters
Journal ArticleDOI
Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study
William T. Creasman,C. Paul Morrow,Brian N. Bundy,Howard D. Homesley,James Graham,Paul B. Heller +5 more
TL;DR: Credence is added to the primary surgical approach with individualized postoperative therapy as indicated for Stage I carcinoma of the endometrium and multiple prognostic factors particularly grade and depth of invasion are related to extrauterine disease.
Journal ArticleDOI
Carcinoma of the Ovary.
A. P M Heintz,Franco Odicino,Patrick Maisonneuve,Michael A. Quinn,J. L. Benedet,William T. Creasman,Hys Ngan,Sergio Pecorelli,U. Beller +8 more
TL;DR: The final histologic findings after surgery (and cytologic ones when available) are to be considered in the staging, which may be modified by histopathologic as well as clinical or radiological evaluation.
Journal ArticleDOI
Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study
C. Paul Morrow,Brian N. Bundy,Robert J. Kurman,William T. Creasman,Paul B Heller,Howard D. Homesley,James Graham +6 more
TL;DR: Data seem to implicate malignant cytology as a serious adverse finding, especially with respect to the risk for regional/distant and abdominal failure, in patients with negative surgical-pathological risk factors.
Journal ArticleDOI
Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Gregorio Delgado,Brian N. Bundy,Richard J. Zaino,Bernd-Uwe Sevin,William T. Creasman,Francis J. Major +5 more
TL;DR: DFI correlated strongly with depth of tumor invasion, both in absolute terms and infractional thirds, and was not significantly different for age, disease status of the surgical margins, tumor description, quadrant involved with tumor, uterine extension, and keratinizing status of tumor cells.
Journal ArticleDOI
Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
William T. Creasman,Franco Odicino,Patrick Maisonneuve,Michael A. Quinn,U. Beller,J. L. Benedet,A. P M Heintz,Hys Ngan,Sergio Pecorelli +8 more
TL;DR: In this paper, the authors grouped carcinoma cases of the corpus with regard to the degree of differentiation of the adenocarcinoma as follows: • G1: 5% of a nonsquamous or nonmorular solid growth pattern • G2: 6−50% of nonsquamy or non-morular liquid growth pattern.